Carriers of an EPCAM deletion had a 75% cumulative risk of colorectal cancer before the age of 70 years, which did not differ significantly from that of carriers of combined EPCAM-MSH2 deletion or mutations in MSH2, but was higher than noted for carriers of MSH6 mutation. The gene discussed is MSH2; the disease is colorectal cancer.